1. Home
  2. HCTI vs INTS Comparison

HCTI vs INTS Comparison

Compare HCTI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCTI
  • INTS
  • Stock Information
  • Founded
  • HCTI 2020
  • INTS 2012
  • Country
  • HCTI United States
  • INTS United States
  • Employees
  • HCTI N/A
  • INTS N/A
  • Industry
  • HCTI Retail: Computer Software & Peripheral Equipment
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCTI Technology
  • INTS Health Care
  • Exchange
  • HCTI Nasdaq
  • INTS Nasdaq
  • Market Cap
  • HCTI 13.5M
  • INTS 10.9M
  • IPO Year
  • HCTI 2021
  • INTS 2023
  • Fundamental
  • Price
  • HCTI $2.61
  • INTS $0.24
  • Analyst Decision
  • HCTI
  • INTS Strong Buy
  • Analyst Count
  • HCTI 0
  • INTS 4
  • Target Price
  • HCTI N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • HCTI 595.0K
  • INTS 3.9M
  • Earning Date
  • HCTI 11-13-2025
  • INTS 11-12-2025
  • Dividend Yield
  • HCTI N/A
  • INTS N/A
  • EPS Growth
  • HCTI N/A
  • INTS N/A
  • EPS
  • HCTI N/A
  • INTS N/A
  • Revenue
  • HCTI $11,866,000.00
  • INTS N/A
  • Revenue This Year
  • HCTI N/A
  • INTS N/A
  • Revenue Next Year
  • HCTI N/A
  • INTS N/A
  • P/E Ratio
  • HCTI N/A
  • INTS N/A
  • Revenue Growth
  • HCTI N/A
  • INTS N/A
  • 52 Week Low
  • HCTI $1.37
  • INTS $0.19
  • 52 Week High
  • HCTI $473.10
  • INTS $4.18
  • Technical
  • Relative Strength Index (RSI)
  • HCTI 43.67
  • INTS 36.68
  • Support Level
  • HCTI $2.40
  • INTS $0.22
  • Resistance Level
  • HCTI $2.77
  • INTS $0.25
  • Average True Range (ATR)
  • HCTI 0.20
  • INTS 0.02
  • MACD
  • HCTI 0.20
  • INTS -0.00
  • Stochastic Oscillator
  • HCTI 79.22
  • INTS 29.27

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: